Destiny Pharma (DEST)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

10.90p
   
  • Change Today:
    -0.100p
  • 52 Week High: 82.00
  • 52 Week Low: 10.50
  • Currency: UK Pounds
  • Shares Issued: 95.51m
  • Volume: 8,986
  • Market Cap: £10.41m
  • RiskGrade: 410

Destiny Pharma Overview

Destiny Pharma, a clinical stage biotechnology company focused on the development of novel anti-microbial drugs, which address the global problem of anti-microbial resistance (AMR).

Key Personnel

CEO: Chris Tovey
CFO and Company Secretary: Shaun Claydon
Chief Scientific Officer: William Love
Non-Executive Chairman: Nigel Rudd
Non-Executive Dir: Aled Williams, Nigel Brooksby, Debra Barker, James Stearns

Contact Details

Address: Unit 36 Sussex Innovation Centre, Science Park Square, Falmer, Brighton, United Kingdom, BN1 9SB
Phone: +44 (0)1273 704 440
Website: http://www.destinypharma.com/

Listings

Sector: Pharma and Biotech(LSE)
Index: FTSE AIM All-Share
ISIN: GB00BDHSP575

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Destiny Pharma Market Data

Currency UK Pounds
Share Price 10.90p
Change Today -0.100p
% Change -0.91 %
52 Week High 82.00
52 Week Low 10.50
Volume 8,986
Shares Issued 95.51m
Market Cap £10.41m
RiskGrade 410

Destiny Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
4.08% below the market average4.08% below the market average4.08% below the market average4.08% below the market average4.08% below the market average
1.96% below the sector average1.96% below the sector average1.96% below the sector average1.96% below the sector average1.96% below the sector average
Price Trend
91.75% below the market average91.75% below the market average91.75% below the market average91.75% below the market average91.75% below the market average
81.13% below the sector average81.13% below the sector average81.13% below the sector average81.13% below the sector average81.13% below the sector average
Income Not Available
Growth Not Available

What The Brokers Say

Strong Buy 0
Buy 1
Neutral 0
Sell 0
Strong Sell 0
Total 1
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Destiny Pharma Dividends

No dividends found

Trades for 17-Jun-2024

Time Volume / Share Price
09:02 8,986 @ 11.13p

Destiny Pharma Key Personnel

CEO Chris Tovey

Top of Page